News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
324,559 Results
Type
Article (26363)
Company Profile (146)
Press Release (298050)
Multimedia
Podcasts (30)
Webinars (11)
Section
Business (91366)
Career Advice (1309)
Deals (14168)
Drug Delivery (80)
Drug Development (38320)
Employer Resources (155)
FDA (7994)
Job Trends (8559)
News (153465)
Policy (13470)
Tag
Academia (1971)
Academic (2)
Accelerated approval (3)
Adcomms (17)
Allergies (75)
Alliances (25247)
ALS (68)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (70)
Approvals (8029)
Artificial intelligence (174)
Autoimmune disease (13)
Automation (12)
Bankruptcy (97)
Best Places to Work (7327)
BIOSECURE Act (13)
Biosimilars (66)
Biotechnology (90)
Bladder cancer (55)
Brain cancer (17)
Breast cancer (157)
Cancer (1191)
Cardiovascular disease (104)
Career advice (1154)
Career pathing (33)
CAR-T (88)
Cell therapy (254)
Cervical cancer (12)
Clinical research (31269)
Collaboration (530)
Compensation (201)
Complete response letters (12)
COVID-19 (1323)
CRISPR (29)
C-suite (172)
Cystic fibrosis (81)
Data (1380)
Decentralized trials (1)
Denatured (21)
Depression (29)
Diabetes (162)
Diagnostics (3356)
Digital health (7)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (72)
Drug pricing (60)
Drug shortages (5)
Duchenne muscular dystrophy (62)
Earnings (26530)
Editorial (16)
Employer branding (24)
Employer resources (134)
Events (49200)
Executive appointments (518)
FDA (8816)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (497)
Gene editing (68)
Generative AI (16)
Gene therapy (213)
GLP-1 (390)
Government (2289)
Grass and pollen (2)
Guidances (35)
Healthcare (9851)
Huntington's disease (15)
IgA nephropathy (20)
Immunology and inflammation (49)
Indications (16)
Infectious disease (1409)
Inflammatory bowel disease (103)
Inflation Reduction Act (8)
Influenza (26)
Intellectual property (51)
Interviews (196)
IPO (6380)
IRA (23)
Job creations (1568)
Job search strategy (1006)
Kidney cancer (2)
Labor market (35)
Layoffs (188)
Leadership (16)
Legal (2171)
Liver cancer (42)
Lung cancer (166)
Lymphoma (92)
Machine learning (3)
Management (52)
Manufacturing (174)
MASH (27)
Medical device (6290)
Medtech (6294)
Mergers & acquisitions (8154)
Metabolic disorders (374)
Multiple sclerosis (50)
NASH (11)
Neurodegenerative disease (45)
Neuropsychiatric disorders (7)
Neuroscience (1207)
NextGen: Class of 2025 (3664)
Non-profit (3456)
Now hiring (38)
Obesity (188)
Opinion (129)
Ovarian cancer (43)
Pain (55)
Pancreatic cancer (39)
Parkinson's disease (100)
Partnered (14)
Patents (106)
Patient recruitment (64)
Peanut (42)
People (33628)
Pharmaceutical (41)
Pharmacy benefit managers (4)
Phase I (9022)
Phase II (13488)
Phase III (11598)
Pipeline (662)
Policy (69)
Postmarket research (1238)
Preclinical (3956)
Press Release (61)
Prostate cancer (61)
Psychedelics (18)
Radiopharmaceuticals (120)
Rare diseases (276)
Real estate (3199)
Recruiting (59)
Regulatory (10178)
Reports (42)
Research institute (1728)
Resumes & cover letters (165)
Rett syndrome (5)
RNA editing (2)
RSV (32)
Schizophrenia (47)
Series A (92)
Series B (55)
Service/supplier (8)
Sickle cell disease (39)
Special edition (8)
Spinal muscular atrophy (108)
Sponsored (24)
Startups (2368)
State (1)
Stomach cancer (8)
Supply chain (29)
Tariffs (9)
The Weekly (9)
Vaccines (321)
Venture capitalists (31)
Weight loss (117)
Women's health (15)
Worklife (18)
Date
Today (103)
Last 7 days (484)
Last 30 days (1500)
Last 365 days (18793)
2025 (6181)
2024 (20046)
2023 (22460)
2022 (27552)
2021 (30632)
2020 (28324)
2019 (25198)
2018 (18732)
2017 (16363)
2016 (15825)
2015 (17415)
2014 (12650)
2013 (10239)
2012 (10756)
2011 (11091)
2010 (10054)
Location
Africa (477)
Alabama (29)
Alaska (7)
Arizona (99)
Arkansas (9)
Asia (18679)
Australia (3392)
California (3399)
Canada (1009)
China (244)
Colorado (135)
Connecticut (173)
Delaware (111)
Europe (46493)
Florida (540)
Georgia (135)
Hawaii (1)
Idaho (23)
Illinois (280)
India (22)
Indiana (253)
Iowa (8)
Japan (131)
Kansas (46)
Kentucky (14)
Louisiana (8)
Maine (14)
Maryland (459)
Massachusetts (2606)
Michigan (127)
Minnesota (205)
Mississippi (2)
Missouri (45)
Montana (17)
Nebraska (10)
Nevada (41)
New Hampshire (18)
New Jersey (1086)
New Mexico (19)
New York (1018)
North Carolina (631)
North Dakota (8)
Northern California (1514)
Ohio (128)
Oklahoma (7)
Oregon (22)
Pennsylvania (730)
Puerto Rico (9)
Rhode Island (16)
South America (627)
South Carolina (9)
Southern California (1232)
Tennessee (43)
Texas (427)
United States (12962)
Utah (81)
Virginia (71)
Washington D.C. (41)
Washington State (235)
West Virginia (1)
Wisconsin (46)
324,559 Results for "realta life sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ReAlta Life Sciences Announces Appointment of Distinguished Immunologist, Laurie Glimcher, M.D., to Board of Directors
April 1, 2025
·
3 min read
Press Releases
ReAlta Life Sciences Announces New Clinical Data for RLS-0071 (pegtarazimod) from Hypoxic Ischemic Encephalopathy Program at Pediatric Academic Societies 2025 Meeting
April 28, 2025
·
5 min read
Press Releases
ReAlta Life Sciences to Present New Clinical Data from Hypoxic Ischemic Encephalopathy Program at Pediatric Academic Societies 2025 Meeting
April 8, 2025
·
2 min read
Press Releases
ReAlta Life Sciences Announces Appointment of Biotechnology Leader Andrew Miller, Ph.D., to Board of Directors
February 26, 2025
·
3 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
BioCapital
ReAlta Life Sciences Announces New Research Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate RLS-0071 as a Medical Countermeasure for Acute Radiation Syndrome
ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”) today announces that the company will be utilizing the preclinical services program offered by the National Institute of Allergy and Infectious Diseases (NIAID) to evaluate RLS-0071 as a medical countermeasure for Acute Radiation Syndrome (ARS).
March 28, 2024
·
3 min read
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
Press Releases
ReAlta Life Sciences Announces Presentation of RLS-0071 (pegtarazimod) Data in aGVHD at American Society of Hematology Annual Meeting
November 5, 2024
·
3 min read
Drug Development
ReAlta Life Sciences Announces Dosing of First Patient in Phase 2 Trial of RLS-0071 for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
ReAlta Life Sciences, Inc. today announced enrollment of the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RLS-0071, an investigational new drug based on ReAlta’s novel EPICC peptide platform, for the treatment of acute exacerbations of chronic obstructive pulmonary disease.
February 21, 2024
·
3 min read
Business
ReAlta Life Sciences Strengthens Board of Directors with Appointment of Two Accomplished Biotechnology Innovators
ReAlta Life Sciences, Inc. today announced the appointment of two experienced R&D leaders, John Baldoni, PhD and Eric Van Gieson, PhD to its Board of Directors, effective immediately.
January 24, 2024
·
5 min read
1 of 32,456
Next
